PacBio
Menlo Park
California
United States
280 articles about PacBio
-
PacBio Grants Equity Incentive Award to New Employee - Aug 19, 2022
8/19/2022
PacBio announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options covering an aggregate of 475,000 shares of PacBio common stock to the Company's recently hired Chief Commercial Officer, Jeff Eidel, under the Pacific Biosciences 2020 Inducement Equity Incentive Plan, effective on August 16, 2022.
-
PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
8/5/2022
PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, California.
-
PacBio Announces Second Quarter 2022 Financial Results
8/3/2022
PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022.
-
PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer
7/21/2022
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial Officer, effective August 16, 2022.
-
PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022
7/18/2022
PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022, at 5:00 pm Eastern Time.
-
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
5/5/2022
PacBio announced that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.
-
PacBio Announces First Quarter 2022 Financial Results
5/4/2022
PacBio announced financial results for the quarter ended March 31, 2022.
-
PacBio transforms access to the epigenome and streamlines workflows
4/21/2022
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel II Systems.
-
PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease
4/21/2022
PacBio announced an expanded research collaboration with Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, to use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic disease.
-
PacBio to Report First Quarter 2022 Financial Results on May 4, 2022
4/20/2022
PacBio announced that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022, at 5:00 pm Eastern Time.
-
Scientists recently announced the complete sequencing of the entire human genome. Biotech company PacBio - and HiFi sequencing - played a big role in this milestone.
-
PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing
4/4/2022
PacBio, a leading provider of high-quality, highly accurate sequencing platforms, announced a new collaboration with global agriculture company, Corteva Agriscience, to develop custom, end-to-end workflows for plant, pest and microbial sequencing.
-
HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology
3/31/2022
PacBio, a leading provider of high-quality, highly accurate sequencing solutions, announced PacBio’s essential contribution to the completion of the first truly complete human reference genome.
-
PacBio Opens European Headquarters in London
3/23/2022
PacBio, a leading developer of high-quality, highly accurate, sequencing platforms, announced the company’s expansion to better serve customers in the Europe, Middle East and Africa region.
-
PacBio Grants Equity Incentive Award to New Employee - Feb 25, 2022
2/25/2022
PacBio announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units covering 50,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan effective on February 22, 2022.
-
KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders
2/16/2022
KK Women’s and Children’s Hospital and PacBio, a leading provider of high-quality, highly accurate sequencing platforms, announced a collaboration to leverage PacBio technology in understanding the genetic causes of neurodevelopmental disorders.
-
PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
2/15/2022
PacBio announced financial results for the quarter and fiscal year ended December 31, 2021.
-
Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call
10/19/2021
Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time.
-
Pacific Biosciences Grants Equity Incentive Award to New Employee - Sep 24, 2021
9/24/2021
Pacific Biosciences of California, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock, and restricted stock units covering 50,000 shares of Pacific Biosciences common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan effective on September 20, 2021.
-
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
9/20/2021
Pacific Biosciences of California, Inc. announced today the companies have closed the transaction under which Pacific Biosciences acquired Omniome.